Pulmonary Disease in Minneapolis, MN
49 verified pulmonary disease doctors in Minneapolis.
Pulmonologists diagnose and treat diseases of the lungs and respiratory system, such as asthma, COPD, and sleep apnea.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Dr. Ken Kunisaki, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Arthur Hanson, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. James Flink, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Conrad Iber, MD
Pulmonary Disease
CMS Open Payments· $8,019 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$8,019
Total received
5
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 92% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Conrad Iber do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Scott Davies, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. William Marinelli, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. James Leatherman, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Andrew Stiehm, MD
Pulmonary Disease
CMS Open Payments· $95.02 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$95.02
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 57th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Andrew Stiehm do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mark Sprenkle, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Robert Shapiro, MD
Pulmonary Disease
CMS Open Payments· $117.14 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$117.14
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 59th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Robert Shapiro do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Kathy Gromer, MD
Pulmonary Disease
CMS Open Payments· $19.66 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$19.66
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 48th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Kathy Gromer do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Shelley Lennox, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mark Stang, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Wilfred Corson, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Robert Bowen, MD
Pulmonary Disease
CMS Open Payments· $37.43 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$37.43
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 52th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Robert Bowen do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mitchell Kaye, MD
Pulmonary Disease
CMS Open Payments· $9,364 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$9,364
Total received
4
Transactions
3
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 93% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Mitchell Kaye do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Joan Fox, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Wayne Stern, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ralph Steele, MD
Pulmonary Disease
CMS Open Payments· $58,407 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$58,407
Total received
45
Transactions
4
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 97% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Ralph Steele do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Patrick Wright, MD
Pulmonary Disease
CMS Open Payments· $15,384 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$15,384
Total received
20
Transactions
4
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is higher than 94% of that group — among the highest recipients.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Patrick Wright do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Michele Leclaire, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jagadish Patil, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jeffrey Rubins, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Christine Wendt, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Maryam Valapour, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Robert Kempainen, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Cornelia Dahm, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Abbie Begnaud, MD
Pulmonary Disease
CMS Open Payments· $135.04 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$135.04
Total received
4
Transactions
3
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 61th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Abbie Begnaud do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Erin Wetherbee, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Susan Burton, MD
Pulmonary Disease
CMS Open Payments· $16.43 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$16.43
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Susan Burton do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Ronald Reilkoff, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Laurel Stephenson, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Kevin Grullon, MD
Pulmonary Disease
CMS Open Payments· $193.54 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$193.54
Total received
4
Transactions
2
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 65th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Kevin Grullon do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Heidi Erickson, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Mohamed Abdullahi, MD
Pulmonary Disease
CMS Open Payments· $22.04 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$22.04
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Mohamed Abdullahi do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Nathaniel Gaeckle, MD
Pulmonary Disease
CMS Open Payments· $15.92 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$15.92
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Nathaniel Gaeckle do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Takehide Umeda, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Anna Milner, MD
Pulmonary Disease
CMS Open Payments· $12.75 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$12.75
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total is on the lower end — around the 46th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Anna Milner do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Kathleen Mahan, MD
Pulmonary Disease
CMS Open Payments· $51.89 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$51.89
Total received
2
Transactions
1
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 54th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Kathleen Mahan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Caroline Davis, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jennifer Wong, MD
Pulmonary Disease
CMS Open Payments· $135.04 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$135.04
Total received
4
Transactions
3
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 61th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Jennifer Wong do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Aiham Jbeli, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Nicholas Ingraham, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Abdallah Abboud, MD
Pulmonary Disease
CMS Open Payments· $276.05 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$276.05
Total received
6
Transactions
3
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 68th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Abdallah Abboud do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Alireza Nathani, MD
Pulmonary Disease
CMS Open Payments· $425.10 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$425.10
Total received
10
Transactions
4
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 72th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Alireza Nathani do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Christine Lambert, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Randal Rovinski, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Jaskiran Khosa, MD
Pulmonary Disease
CMS Open Payments· $462.01 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$462.01
Total received
6
Transactions
3
Paying companies
Top paying companies
Among the 13,317 pulmonary disease doctors we've analyzed, about 54% received any industry payment (median $474 among those who did). This doctor's total ranks around the 73th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US pulmonary disease doctors.
Payments to Jaskiran Khosa do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Madia Ampey, MD
Pulmonary Disease
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.